Dietary Supplements and Aging Muscle
Not Applicable
Completed
- Conditions
- Sarcopenia
- Interventions
- Dietary Supplement: Juven
- Registration Number
- NCT01057082
- Lead Sponsor
- University of Alabama at Birmingham
- Brief Summary
The purpose of this study is to determine whether older adults (ages 65-89) who consume the dietary supplement Juven (Abbott Laboratories) versus placebo for 6 months will demonstrate increases in fat-free mass, muscle volume,and physical function.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
- Ages 65-89
- Ambulatory
Exclusion Criteria
- Cognitive impairment
- History of renal or hepatic disease
- History of hypotension
- History of peripheral artery disease
- Uncontrolled hypertension
- Uncontrolled diabetes
- Self-reported claustrophobia
- Current smoker
- Steroid or androgen use with the previous 3 months
- Individuals with pacemakers and defibrillators
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Juven Juven Participants in the treatment arm will receive the dietary supplement Juven. Placebo Juven -
- Primary Outcome Measures
Name Time Method Fat-free mass as determined by a four-compartment model of body composition Baseline, 3-months, 6-months
- Secondary Outcome Measures
Name Time Method Appendicular lean mass as determined by dual energy X-ray absorptiometry Baseline, 3-months, 6-months Muscle volume as determined by magnetic resonance imaging Baseline and 6-months Physical function as determined by questionnaire and a battery of physical performance tests Baseline and 6 months
Trial Locations
- Locations (1)
University of Alabama at Birmingham
🇺🇸Birmingham, Alabama, United States